Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Combined administration of quinidine and propafenone for atrial fibrillation: the CAQ-PAF study.

O'Hara GE, Philippon F, Gilbert M, Champagne J, Michaud V, Charbonneau L, Pruneau G, Hamelin BA, Geelen P, Turgeon J.

J Clin Pharmacol. 2012 Feb;52(2):171-9. doi: 10.1177/0091270011399574.

PMID:
21508180
2.

Increased risk of myocardial infarction associated with angiotensin-converting enzyme gene polymorphism is age dependent.

Hamelin BA, Zakrzewski-Jakubiak M, Robitaille NM, Bogaty P, Labbé L, Turgeon J.

J Clin Pharmacol. 2011 Sep;51(9):1286-92. doi: 10.1177/0091270010382420. Epub 2010 Dec 8.

PMID:
21148050
3.

Toward optimal treatment in women: the effect of sex on metoprolol-diphenhydramine interaction.

Sharma A, Pibarot P, Pilote S, Dumesnil JG, Arsenault M, Bélanger PM, Meibohm B, Hamelin BA.

J Clin Pharmacol. 2010 Feb;50(2):214-25. doi: 10.1177/0091270009340417. Epub 2009 Nov 30.

PMID:
19948945
4.

The ACE-DD genotype is associated with endothelial dysfunction in postmenopausal women.

Méthot J, Hamelin BA, Arsenault M, Bogaty P, Plante S, Poirier P.

Menopause. 2006 Nov-Dec;13(6):959-66.

PMID:
17003740
5.

Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT-PCR.

Caron E, Rioux N, Nicolas O, Lebel-Talbot H, Hamelin BA.

J Biochem Mol Toxicol. 2005;19(6):368-78.

PMID:
16421897
6.

ACE-DD genotype is associated with the occurrence of acute coronary syndrome in postmenopausal women.

Méthot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P.

Int J Cardiol. 2005 Dec 7;105(3):308-14.

PMID:
16274774
7.

Modulation of metoprolol pharmacokinetics and hemodynamics by diphenhydramine coadministration during exercise testing in healthy premenopausal women.

Sharma A, Pibarot P, Pilote S, Dumesnil JG, Arsenault M, Bélanger PM, Meibohm B, Hamelin BA.

J Pharmacol Exp Ther. 2005 Jun;313(3):1172-81. Epub 2005 Feb 17.

8.

Does hormonal status influence the clinical presentation of acute coronary syndromes in women?

Méthot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P.

J Womens Health (Larchmt). 2004 Jul-Aug;13(6):695-702.

PMID:
15333284
9.

A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study.

Sharma A, Pilote S, Bélanger PM, Arsenault M, Hamelin BA.

Br J Clin Pharmacol. 2004 Sep;58(3):288-97.

10.

Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women.

Hamelin BA, Méthot J, Arsenault M, Pilote S, Poirier P, Plante S, Bogaty P.

Am J Med. 2003 May;114(7):599-602. No abstract available.

PMID:
12753884
11.
12.

Diphenhydramine alters the disposition of venlafaxine through inhibition of CYP2D6 activity in humans.

Lessard E, Yessine MA, Hamelin BA, Gauvin C, Labbé L, O'Hara G, LeBlanc J, Turgeon J.

J Clin Psychopharmacol. 2001 Apr;21(2):175-84.

PMID:
11270914
13.

Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates.

Labbé L, Sirois C, Pilote S, Arseneault M, Robitaille NM, Turgeon J, Hamelin BA.

Pharmacogenetics. 2000 Jul;10(5):425-38.

PMID:
10898112
14.

Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity.

Hamelin BA, Bouayad A, Méthot J, Jobin J, Desgagnés P, Poirier P, Allaire J, Dumesnil J, Turgeon J.

Clin Pharmacol Ther. 2000 May;67(5):466-77.

PMID:
10824625
15.

Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.

Lessard E, Yessine MA, Hamelin BA, O'Hara G, LeBlanc J, Turgeon J.

Pharmacogenetics. 1999 Aug;9(4):435-43.

PMID:
10780263
16.

Involvement of CYP2D6 activity in the N-oxidation of procainamide in man.

Lessard E, Hamelin BA, Labbé L, O'Hara G, Bélanger PM, Turgeon J.

Pharmacogenetics. 1999 Dec;9(6):683-96.

PMID:
10634131
17.

CYP2D6 mutations and therapeutic outcome in schizophrenic patients.

Hamelin BA, Dorson PG, Pabis D, Still D, Bouchard RH, Pourcher E, Rail J, Turgeon J, Crismon ML.

Pharmacotherapy. 1999 Sep;19(9):1057-63.

PMID:
10610012
18.

Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current.

Drolet B, Vincent F, Rail J, Chahine M, Deschênes D, Nadeau S, Khalifa M, Hamelin BA, Turgeon J.

J Pharmacol Exp Ther. 1999 Mar;288(3):1261-8.

19.

Block of potassium currents in guinea pig ventricular myocytes and lengthening of cardiac repolarization in man by the histamine H1 receptor antagonist diphenhydramine.

Khalifa M, Drolet B, Daleau P, Lefez C, Gilbert M, Plante S, O'Hara GE, Gleeton O, Hamelin BA, Turgeon J.

J Pharmacol Exp Ther. 1999 Feb;288(2):858-65.

20.

In vitro characterization of cytochrome P450 2D6 inhibition by classic histamine H1 receptor antagonists.

Hamelin BA, Bouayad A, Drolet B, Gravel A, Turgeon J.

Drug Metab Dispos. 1998 Jun;26(6):536-9.

21.

Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors.

Hamelin BA, Turgeon J.

Trends Pharmacol Sci. 1998 Jan;19(1):26-37. Review.

PMID:
9509899
22.

The effect of timing of a standard meal on the pharmacokinetics and pharmacodynamics of the novel atypical antipsychotic agent ziprasidone.

Hamelin BA, Allard S, Laplante L, Miceli J, Wilner KD, Tremblay J, LeBel M.

Pharmacotherapy. 1998 Jan-Feb;18(1):9-15.

PMID:
9469675
23.
24.
25.

Role of CYP2D6 in the N-hydroxylation of procainamide.

Lessard E, Fortin A, Bélanger PM, Beaune P, Hamelin BA, Turgeon J.

Pharmacogenetics. 1997 Oct;7(5):381-90.

PMID:
9352574
26.
27.

The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin.

Hamelin BA, Turgeon J, Vallée F, Bélanger PM, Paquet F, LeBel M.

Clin Pharmacol Ther. 1996 Nov;60(5):512-21.

PMID:
8941024
28.

Caffeine metabolism in cystic fibrosis: enhanced xanthine oxidase activity.

Hamelin BA, Xu K, Vallé F, Manseau L, Richer M, LeBel M.

Clin Pharmacol Ther. 1994 Nov;56(5):521-9.

PMID:
7955816
29.

Cefepime pharmacokinetics in cystic fibrosis.

Hamelin BA, Moore N, Knupp CA, Ruel M, Vallée F, LeBel M.

Pharmacotherapy. 1993 Sep-Oct;13(5):465-70.

PMID:
8247913
30.

Fleroxacin pharmacokinetics in patients with liver cirrhosis.

Blouin RA, Hamelin BA, Smith DA, Foster TS, John WJ, Welker HA.

Antimicrob Agents Chemother. 1992 Mar;36(3):632-8.

31.

In vivo and in vitro beta 2-adrenergic receptor responsiveness in young and elderly asthmatics.

Hamelin BA, Blouin RA, Wolf KM, Clifton GD, Chandler MH.

Pharmacotherapy. 1992;12(5):376-82.

PMID:
1331993

Supplemental Content

Loading ...
Support Center